Why is Sudeep Pharma Ltd falling/rising?

As of 09-Aug, Sudeep Pharma Ltd's stock price is currently falling, with a change of -15.7, representing a decline of 1.61%. Despite this decrease, the stock has shown strong performance over the past week and month, with returns of +8.94% and +18.11%, respectively. However, today's performance indicates a trend reversal after three consecutive days of gains, which may have contributed to the current decline.The stock reached a new 52-week and all-time high of Rs 1000.25 earlier today but has since fallen, touching an intraday low of Rs 947.8. This volatility suggests that while there was significant upward momentum, it has not been sustained, leading to the current drop in price. Additionally, the stock underperformed its sector by -1.73% today, which may have influenced investor sentiment negatively.Moreover, there has been a decrease in investor participation, with delivery volume falling by -2.93% compared to the 5-day average. This decline in trading activity could indicate reduced interest from investors, further contributing to the stock's downward movement. Despite these challenges, Sudeep Pharma maintains a strong position with high management efficiency and a low debt-to-EBITDA ratio, which may support its long-term prospects.

Which are the latest news on Sudeep Pharma?

Sudeep Pharma Gains 8.94%: 5 Key Factors Driving the Week’s Momentum Broad-Based Technical Strength Lifts Sudeep Pharma Ltd to 52-Week High of Rs 1000.25

Are Sudeep Pharma Ltd latest results good or bad?

Sudeep Pharma Ltd's latest results present a mixed picture. On one hand, the company reported a net profit of ₹40.55 crores for Q1 FY27, which is a significant increase of 31.61% year-on-year. Additionally, the revenue grew by 26.70% compared to the same quarter last year, indicating strong market traction.However, there are concerns regarding the sequential performance. The net profit declined by 17.04% from the previous quarter, which raises questions about the sustainability of their growth. The operating margin also saw a slight contraction to 34.69%, down from 35.13% year-on-year, reflecting some cost pressures.Overall, while the year-on-year growth figures are encouraging, the quarter-on-quarter declines in both net profit and revenue suggest that the company may be facing challenges that need to be addressed. Investors should monitor these trends closely to gauge the company's future performance.

Should I buy, sell or hold Sudeep Pharma Ltd?

Based on the current analysis of Sudeep Pharma Ltd, it would be advisable to hold your position in the company for now. The company demonstrates high management efficiency with a strong return on equity (ROE) of 19.6%, indicating effective management of shareholder funds. Additionally, it has a low debt to EBITDA ratio of 0.68 times, which suggests a solid ability to service its debt obligations.However, there are concerns regarding long-term growth, as the operating profit has stagnated with an annual growth rate of 0% over the past five years. Recent results also show a decline in profit after tax (PAT) for the latest quarter, which fell by 6.2% compared to the previous four-quarter average, despite a significant growth in interest.The valuation appears high with a price to book value of 12.2, and there has been a slight decrease in institutional investor participation, which can be a red flag since these investors typically have better insights into company fundamentals.Given these mixed signals, maintaining your current position seems prudent until there are clearer signs of growth or improvement in the company's performance.

When is the next results date for Sudeep Pharma Ltd?

The next results date for Sudeep Pharma Ltd is scheduled for August 4, 2026.

SUDEEPPHRM Share Price | Sudeep Pharma Ltd Stock Analysis & Recommendation

Key Events This Week

3 Aug: New 52-week high at Rs.912.65 and all-time high near Rs.909.95

5 Aug: Intraday volatility with new 52-week and all-time highs up to Rs.928.9 amid strong volume

6 Aug: New 52-week and all-time high at Rs.988.7, continuing upward momentum

7 Aug: Stock hits Rs.1000.25, marking a significant milestone

7 Aug: Week closes at Rs.958.05, up 8.94% for the week

Week Ope...

Read full news article

Broad-Based Technical Strength Lifts Sudeep Pharma Ltd to 52-Week High of Rs 1000.25

Surging past the Rs 1000 mark for the first time, Sudeep Pharma Ltd has reached a new 52-week high on 7 Aug 2026, propelled by a confluence of bullish technical indicators and sustained price momentum over recent sessions.

Read full news article

Sudeep Pharma Ltd Hits All-Time High of Rs 1000.25 as Momentum Builds Across Timeframes

Extending its winning streak to four consecutive sessions, Sudeep Pharma Ltd surged to a fresh all-time high of Rs 1000.25 on 07 Aug 2026, outpacing its sector and the broader market with a 0.29% gain on the day against a Sensex decline of 0.35%.

Read full news article

[ { "link": "quarterly", "btn_text": "All Quarterly Results", "header": "Quarterly Results Snapshot (Standalone) - Jun'26 - QoQ", "rhs": [ { "prefix": "Net Sales ", "suffix": "QoQ Growth in quarter ended Jun 2026 is 31.82% vs -11.20% in Mar 2026", "dir": 1 }, { "prefix": "Standalone Net Profit ", "suffix": "QoQ Growth in quarter ended Jun 2026 is 31.28% vs -4.09% in Mar 2026", "dir": 1 } ], "table": { "header": [ "Jun'26", "Mar'26", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "105.68", "val2": "80.17", "chgp": "31.82%", "chgp_class": "positive" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "39.19", "val2": "28.89", "chgp": "35.65%", "chgp_class": "positive" }, { "field": "Interest", "val1": "1.76", "val2": "1.97", "chgp": "-10.66%", "chgp_class": "positive" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "33.83", "val2": "25.77", "chgp": "31.28%", "chgp_class": "positive" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "37.08%", "val2": "36.04%", "chgp": "1.04%", "chgp_class": "positive" } ] } }, { "link": "half-yearly", "btn_text": "All Half Yearly Results", "header": "Half Yearly Results Snapshot (Standalone) - Sep'25", "rhs": [ { "prefix": "Net Sales ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 }, { "prefix": "Standalone Net Profit ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 } ], "table": { "header": [ "Sep'25", "Sep'24", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "168.06", "val2": "168.40", "chgp": "-0.20%", "chgp_class": "negative" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "61.27", "val2": "60.03", "chgp": "2.07%", "chgp_class": "positive" }, { "field": "Interest", "val1": "3.47", "val2": "1.99", "chgp": "74.37%", "chgp_class": "negative" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "54.95", "val2": "41.98", "chgp": "30.90%", "chgp_class": "positive" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "36.46%", "val2": "35.65%", "chgp": "0.81%", "chgp_class": "positive" } ] } }, { "link": "nine-monthly", "btn_text": "All Nine Monthly Results", "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25", "rhs": [ { "prefix": "Net Sales ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 }, { "prefix": "Standalone Net Profit ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 } ], "table": { "header": [ "Dec'25", "Dec'24", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "258.34", "val2": "251.88", "chgp": "2.56%", "chgp_class": "positive" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "90.88", "val2": "86.49", "chgp": "5.08%", "chgp_class": "positive" }, { "field": "Interest", "val1": "4.10", "val2": "3.24", "chgp": "26.54%", "chgp_class": "negative" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "81.82", "val2": "62.61", "chgp": "30.68%", "chgp_class": "positive" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "35.18%", "val2": "34.34%", "chgp": "0.84%", "chgp_class": "positive" } ] } }, { "link": "annual", "btn_text": "All Annual Results", "header": "Annual Results Snapshot (Consolidated) - Mar'26", "rhs": [ { "prefix": "Net Sales ", "suffix": "YoY Growth in year ended Mar 2026 is 27.94% vs 9.30% in Mar 2025", "dir": 1 }, { "prefix": "Consolidated Net Profit ", "suffix": "YoY Growth in year ended Mar 2026 is 24.62% vs 4.16% in Mar 2025", "dir": 1 } ], "table": { "header": [ "Mar'26", "Mar'25", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "642.26", "val2": "502.00", "chgp": "27.94%", "chgp_class": "positive" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "221.91", "val2": "189.95", "chgp": "16.83%", "chgp_class": "positive" }, { "field": "Interest", "val1": "7.60", "val2": "5.85", "chgp": "29.91%", "chgp_class": "negative" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Consolidate Net Profit", "val1": "172.89", "val2": "138.73", "chgp": "24.62%", "chgp_class": "positive" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "34.55%", "val2": "37.84%", "chgp": "-3.29%", "chgp_class": "negative" } ] } } ]